These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 37424449

  • 1. Evaluating Technologies to Identify Fentanyl and Adulterants in Street Drug Paraphernalia: Qualitative Perspectives of Service Providers and Their Clientele.
    Santelices C, Matsumoto A, Boulad M, Stopka TJ.
    Subst Use Misuse; 2023; 58(12):1528-1535. PubMed ID: 37424449
    [Abstract] [Full Text] [Related]

  • 2. "It wasn't here, and now it is. It's everywhere": fentanyl's rising presence in Oregon's drug supply.
    Shin SS, LaForge K, Stack E, Pope J, Leichtling G, Larsen JE, Leahy JM, Seaman A, Hoover D, Chisholm L, Blazes C, Baker R, Byers M, Branson K, Korthuis PT.
    Harm Reduct J; 2022 Jul 11; 19(1):76. PubMed ID: 35818072
    [Abstract] [Full Text] [Related]

  • 3. How do we understand the value of drug checking as a component of harm reduction services? A qualitative exploration of client and provider perspectives.
    Moran L, Ondocsin J, Outram S, Ciccarone D, Werb D, Holm N, Arnold EA.
    Harm Reduct J; 2024 May 11; 21(1):92. PubMed ID: 38734643
    [Abstract] [Full Text] [Related]

  • 4. Barriers to, and Facilitators of, Checking Drugs for Adulterants in the Era of Fentanyl and Xylazine: Qualitative Study.
    Aronson ID, Ardouin-Guerrier MA, Baus JE, Bennett AS.
    JMIR Form Res; 2024 Jul 03; 8():e56755. PubMed ID: 38959505
    [Abstract] [Full Text] [Related]

  • 5. Drug checking as a potential strategic overdose response in the fentanyl era.
    Laing MK, Tupper KW, Fairbairn N.
    Int J Drug Policy; 2018 Dec 03; 62():59-66. PubMed ID: 30359874
    [Abstract] [Full Text] [Related]

  • 6. Recommendations from people who use drugs in Philadelphia, PA about structuring point-of-care drug checking.
    Reed MK, Borne E, Esteves Camacho T, Kelly M, Rising KL.
    Harm Reduct J; 2024 Jan 30; 21(1):26. PubMed ID: 38287409
    [Abstract] [Full Text] [Related]

  • 7. Stakeholder perspectives on implementing fentanyl drug checking: Results from a multi-site study.
    Glick JL, Christensen T, Park JN, McKenzie M, Green TC, Sherman SG.
    Drug Alcohol Depend; 2019 Jan 01; 194():527-532. PubMed ID: 30551090
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluating fentanyl test strips as a harm reduction strategy in rural and urban counties: study protocol for a randomized controlled trial.
    Short Mejia A, Smith GA, Fernandez SA, Freisthler B, Grella C, Michaels NL.
    Trials; 2024 Sep 04; 25(1):587. PubMed ID: 39232778
    [Abstract] [Full Text] [Related]

  • 10. Effect of witnessing an overdose on the use of drug checking services among people who use illicit drugs in Vancouver, Canada.
    Beaulieu T, Hayashi K, Nosova E, Milloy MJ, DeBeck K, Wood E, Kerr T, Ti L.
    Am J Drug Alcohol Abuse; 2020 Jul 03; 46(4):506-511. PubMed ID: 31983241
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. What is needed for implementing drug checking services in the context of the overdose crisis? A qualitative study to explore perspectives of potential service users.
    Wallace B, van Roode T, Pagan F, Phillips P, Wagner H, Calder S, Aasen J, Pauly B, Hore D.
    Harm Reduct J; 2020 May 12; 17(1):29. PubMed ID: 32398090
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Paper spray mass spectrometry: A new drug checking tool for harm reduction in the opioid overdose crisis.
    Vandergrift GW, Gill CG.
    J Mass Spectrom; 2019 Sep 12; 54(9):729-737. PubMed ID: 31432563
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada.
    Karamouzian M, Dohoo C, Forsting S, McNeil R, Kerr T, Lysyshyn M.
    Harm Reduct J; 2018 Sep 10; 15(1):46. PubMed ID: 30200991
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting.
    Tupper KW, McCrae K, Garber I, Lysyshyn M, Wood E.
    Drug Alcohol Depend; 2018 Sep 01; 190():242-245. PubMed ID: 30064061
    [Abstract] [Full Text] [Related]

  • 18. Take-home drug checking as a novel harm reduction strategy in British Columbia, Canada.
    Klaire S, Janssen RM, Olson K, Bridgeman J, Korol EE, Chu T, Ghafari C, Sabeti S, Buxton JA, Lysyshyn M.
    Int J Drug Policy; 2022 Aug 01; 106():103741. PubMed ID: 35671687
    [Abstract] [Full Text] [Related]

  • 19. Insights from Drug Checking Programs: Practicing Bootstrap Public Health Whilst Tailoring to Local Drug User Needs.
    Ondocsin J, Ciccarone D, Moran L, Outram S, Werb D, Thomas L, Arnold EA.
    Int J Environ Res Public Health; 2023 May 30; 20(11):. PubMed ID: 37297603
    [Abstract] [Full Text] [Related]

  • 20. Current attitudes toward drug checking services and a comparison of expected with actual drugs present in street drug samples collected from opioid users.
    Swartz JA, Lieberman M, Jimenez AD, Mackesy-Amiti ME, Whitehead HD, Hayes KL, Taylor L, Prete E.
    Harm Reduct J; 2023 Jul 07; 20(1):87. PubMed ID: 37420196
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.